Cuba says three-shot Abdala vaccine 92.28% effective against Covid-19

On Monday, Cuba said its three-shot Abdala vaccine has proven to be 92.28 per cent effective against Covid-19 in the last stage of clinical trials.

Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials. Golpeados por dos pandemias (#COVID19 y #Bloqueo), nuestros científicos del Finlay y CIGB, han saltado por encima de todos los obstáculos y nos han dado dos vacunas muy efectivas: #SOBERANA02 y #Abdala. pic.twitter.com/4DOfJiRh3o The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. "Hit by the pandemic, our scientists at the Finlay Institute and Center for Genetic Engineering and Biotechnology have risen above all the obstacles and given us two very effective vaccines," President Miguel Diaz-Canel tweeted.